Home › Medulloblastoma › Michigan
Medulloblastoma clinical trials in Michigan
4 studies for Medulloblastoma are looking for participants at sites in Michigan.
Cities in Michigan
Molecular and Clinical Risk-Directed Therapy for Infants and Young Children With Newly Diagnosed Medulloblastoma
- C.S. MOTT Children's Hospital, University of Michigan, Ann Arbor
RecruitingPhase 2
59 Months · All sexes · Updated Sep 15, 2026 · NCT05535166Antiangiogenic Therapy for Children With Recurrent Medulloblastoma, Ependymoma, ATRT and Rare CNS Tumors
- Helen DeVos Children's Hospital, Grand Rapids
RecruitingPhase 2
Up to age 19 · All sexes · Updated Sep 10, 2026 · NCT01356290A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss
- C S Mott Children's Hospital, Ann Arbor
- Children's Hospital of Michigan, Detroit
- Corewell Health Grand Rapids Hospitals - Helen DeVos Children's Hospital, Grand Rapids
- and 1 more
RecruitingPhase 3
Ages 4 to 21 · All sexes · Updated Aug 25, 2026 · NCT05382338PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma
- C.S. Mott Children's Hospital, Ann Arbor
RecruitingPhase 2
Ages 3 to 39 · All sexes · Updated Aug 24, 2026 · NCT05096481From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.